D.E. Shaw & Co
AHCO icon

D.E. Shaw & Co’s AdaptHealth AHCO Stock Holding History

D.E. Shaw & Co’s Portfolio AHCO Stock Details AHCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.25M Buy
407,617
+72,100
+21% +$805K ﹤0.01% 2534
2026
Q1 		$3.99M Buy
335,517
+32,928
+11% +$337K ﹤0.01% 2349
2025
Q4 		$3.01M Buy
302,589
+36,094
+14% +$345K ﹤0.01% 2724
2025
Q3 		$2.39M Buy
266,495
+27,860
+12% +$258K ﹤0.01% 2838
2025
Q2 		$2.25M Sell
238,635
-142,881
-37% -$1.26M ﹤0.01% 2651
2025
Q1 		$4.14M Buy
381,516
+175,926
+86% +$1.77M ﹤0.01% 2038
2024
Q4 		$1.96M Sell
205,590
-297,292
-59% -$3.01M ﹤0.01% 2753
2024
Q3 		$5.65M Sell
502,882
-14,934
-3% -$159K ﹤0.01% 1851
2024
Q2 		$5.18M Buy
517,816
+13,384
+3% +$136K ﹤0.01% 1813
2024
Q1 		$5.81M Buy
+504,432
New +$4.28M 0.01% 1778
2022
Q3 		– Sell
-241,152
Closed -$4.35M – 5150
2022
Q2 		$4.35M Buy
+241,152
New +$3.92M 0.01% 2298
2021
Q1 		– Sell
-38,621
Closed -$1.45M – 4004
2020
Q4 		$1.45M Buy
+38,621
New +$1.19M ﹤0.01% 2771

Other funds holding AHCO

OCA
OEP Capital Advisors New York $170M AUM 10.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SC
SkyKnight Capital San Francisco, California $94.1M AUM 10.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
RP
Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

D.E. Shaw & Co's AHCO Position: Q2 2026 in Review

D.E. Shaw & Co increased its AdaptHealth (AHCO) stake by 21% in Q2 2026, buying an estimated $805K and bringing the position to 407,617 shares worth $4.25M. The position accounts for ﹤0.01% of the portfolio, ranked #2534.

D.E. Shaw & Co first reported a position in AHCO in Q4 2020 and has held it in 12 quarters since. The position peaked at $5.81M in Q1 2024. 239 funds tracked by Wall St. Rank hold AHCO as of Q2 2026.

  • D.E. Shaw & Co held 407,617 shares of AdaptHealth worth $4.25M as of Q2 2026.
  • D.E. Shaw & Co bought 72,100 AdaptHealth shares in Q2 2026, an estimated $805K.
  • AdaptHealth made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q2 2026, its #2534 holding.
  • D.E. Shaw & Co first reported a position in AdaptHealth in Q4 2020 and has held it in 12 quarters since.
  • D.E. Shaw & Co's AdaptHealth position peaked at $5.81M in Q1 2024.
  • 239 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.